Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome
Background Hereditary leiomyomatosis and renal cell cancer syndrome is a rare autosomal dominant hereditary syndrome. Previously, we published the largest cohort of FH mutation carriers in Spain and observed a highly recurrent missense heterozygous variant, FH(NM_000143.4):c.1118A > G p.(Asn373Ser), in 104 individuals from 31 apparently unrelated families. Here, we aimed to establish its founder effect and characterize the associated clinical phenotype. Results Haplotype analysis confirmed that families shared a common haplotype (32/38 markers) spanning 0.61–0.82 Mb, indicating this recurrent variant was inherited from a founder ancestor. Cutaneous and uterine leiomyomatosis were diagnosed in 64.6% (64/99) and 98% (50/51) of patients, respectively, and renal cell cancer was present in 10.4% (10/96). The pathogenic FH_c.1118A > G variant is a Spanish founder mutation that originated 12–26 generations ago. We estimate that the variant may have appeared between 1370 and 1720. Individuals carrying this founder mutation had similar frequency of renal cell cancer and a higher frequency of renal cysts and leiomyomas than those in other cohorts of this syndrome. Conclusions In the Spanish province of Alicante there is a high prevalence of HLRCC because of the founder mutation FH c.1118A > G; p.(Asn373Ser). The characterization of founder mutations provides accurate and specific information regarding their penetrance and expressivity. In individuals with suspected HLRCC from the province of Alicante, genetic testing by direct analysis of the founder FH c.1118A > G; p.(Asn373Ser) mutation may be a faster and more efficient diagnostic tool compared with complete gene sequencing..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Orphanet journal of rare diseases - 19(2024), 1 vom: 26. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sánchez-Heras, Ana Beatriz [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Common ancestor |
|---|
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1186/s13023-024-03017-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054540461 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054540461 | ||
| 003 | DE-627 | ||
| 005 | 20240127064632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240127s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13023-024-03017-z |2 doi | |
| 035 | |a (DE-627)SPR054540461 | ||
| 035 | |a (SPR)s13023-024-03017-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sánchez-Heras, Ana Beatriz |e verfasserin |0 (orcid)0000-0003-1742-5374 |4 aut | |
| 245 | 1 | 0 | |a Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Background Hereditary leiomyomatosis and renal cell cancer syndrome is a rare autosomal dominant hereditary syndrome. Previously, we published the largest cohort of FH mutation carriers in Spain and observed a highly recurrent missense heterozygous variant, FH(NM_000143.4):c.1118A > G p.(Asn373Ser), in 104 individuals from 31 apparently unrelated families. Here, we aimed to establish its founder effect and characterize the associated clinical phenotype. Results Haplotype analysis confirmed that families shared a common haplotype (32/38 markers) spanning 0.61–0.82 Mb, indicating this recurrent variant was inherited from a founder ancestor. Cutaneous and uterine leiomyomatosis were diagnosed in 64.6% (64/99) and 98% (50/51) of patients, respectively, and renal cell cancer was present in 10.4% (10/96). The pathogenic FH_c.1118A > G variant is a Spanish founder mutation that originated 12–26 generations ago. We estimate that the variant may have appeared between 1370 and 1720. Individuals carrying this founder mutation had similar frequency of renal cell cancer and a higher frequency of renal cysts and leiomyomas than those in other cohorts of this syndrome. Conclusions In the Spanish province of Alicante there is a high prevalence of HLRCC because of the founder mutation FH c.1118A > G; p.(Asn373Ser). The characterization of founder mutations provides accurate and specific information regarding their penetrance and expressivity. In individuals with suspected HLRCC from the province of Alicante, genetic testing by direct analysis of the founder FH c.1118A > G; p.(Asn373Ser) mutation may be a faster and more efficient diagnostic tool compared with complete gene sequencing. | ||
| 650 | 4 | |a Haplotypes |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Founder mutation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Common ancestor |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hereditary leiomyomatosis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Renal cell cancer |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Fumarate hydratase |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Leiomyoma |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Dámaso, Estela |4 aut | |
| 700 | 1 | |a Castillejo, Adela |4 aut | |
| 700 | 1 | |a Robledo, Mercedes |4 aut | |
| 700 | 1 | |a Teulé, Alexandre |4 aut | |
| 700 | 1 | |a Lázaro, Conxi |4 aut | |
| 700 | 1 | |a Sánchez-Martínez, Rosario |4 aut | |
| 700 | 1 | |a Zúñiga, Ángel |4 aut | |
| 700 | 1 | |a López-Fernández, Adrià |4 aut | |
| 700 | 1 | |a Balmaña, Judith |4 aut | |
| 700 | 1 | |a Robles, Luis |4 aut | |
| 700 | 1 | |a Ramon y Cajal, Teresa |4 aut | |
| 700 | 1 | |a Castillejo, M. Isabel |4 aut | |
| 700 | 1 | |a Ibañez, Raquel Perea |4 aut | |
| 700 | 1 | |a Sevila, Carmen Martínez |4 aut | |
| 700 | 1 | |a Sánchez-Mira, Andrea |4 aut | |
| 700 | 1 | |a Escandell, Inés |4 aut | |
| 700 | 1 | |a Gómez, Luís |4 aut | |
| 700 | 1 | |a Berbel, Pere |4 aut | |
| 700 | 1 | |a Soto, José Luis |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Orphanet journal of rare diseases |d London : BioMed Central, 2006 |g 19(2024), 1 vom: 26. Jan. |w (DE-627)SPR029480884 |w (DE-600)2225857-7 |x 1750-1172 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:1 |g day:26 |g month:01 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13023-024-03017-z |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2024 |e 1 |b 26 |c 01 | ||